Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.27 AUD | +3.15% |
|
+6.35% | -14.82% |
05-28 | Transcript : Neuren Pharmaceuticals Limited - Shareholder/Analyst Call | |
05-27 | Neuren Phase 2 Trial Shows Significant Improvements in Pitt Hopkins Syndrome | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- Official Publications